Search clinical trials for: Velcade and Sorafenib
Total 269739 results
-
New Mexico Cancer Care AllianceTerminatedMetastatic Renal Cell CarcinomaUnited States
-
SCRI Development Innovations, LLCBayerCompletedMultiple MyelomaUnited States
-
Yabao Pharmaceutical GroupCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdTigermed Consulting Co., LtdCompleted
-
University of ArkansasMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
BayerAmgenCompleted
-
Ohio State University Comprehensive Cancer CenterBayerTerminated
-
Technical University of MunichCompleted
-
Ottawa Hospital Research InstituteBayerCompletedMetastatic Colorectal CancerCanada
-
British Columbia Cancer AgencyWithdrawnLocally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)Canada
-
Cancer Institute and Hospital, Chinese Academy...CompletedHepatocellular Carcinoma, Radiotherapy, SorafenibChina
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung CarcinomaUnited States
-
Accelerated Community Oncology Research NetworkBayerTerminatedRenal Cell CarcinomaUnited States
-
China Medical University HospitalUnknown
-
China Medical University HospitalUnknownHepatocellular CarcinomaTaiwan
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Columbia UniversityUnknownMesotheliomaUnited States
-
National Cancer Centre, SingaporeTerminated
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedA Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple MyelomaMultiple MyelomaBelgium, France, Germany
-
BayerCompletedHepatocellular CarcinomaTaiwan
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Recurrent Thyroid Gland Medullary Carcinoma | Hereditary Thyroid Gland Medullary Carcinoma | Locally Advanced Thyroid Gland Medullary Carcinoma | Sporadic Thyroid Gland Medullary Carcinoma | Stage III Thyroid Gland Medullary... and other conditionsUnited States
-
Indiana University School of MedicineBayerCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Promyelocytic, AcuteUnited States
-
National Cancer Institute (NCI)Active, not recruitingGastrointestinal Stromal TumorUnited States
-
National Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic... and other conditionsUnited States
-
Yale UniversityBayer; Biocompatibles UK LtdCompletedHepatocellular Carcinoma | HepatomaUnited States
-
Yonsei UniversityCompletedHepatocellular CarcinomaKorea, Republic of
-
University of ChicagoBayerTerminatedEsophageal CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...China Medical University, China; Changhai Hospital; Fudan University; Peking Union... and other collaboratorsUnknown
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedMetastatic Colorectal Cancer Patients With KRAS Mutated TumorsFrance
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.CompletedGraft Versus Host DiseaseUnited States
-
University Hospital, ToulouseIntergroupe Francophone du MyelomeCompletedMultiple MyelomaFrance
-
University of UtahMillennium Pharmaceuticals, Inc.TerminatedCancer | Multiple Myeloma | MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedCarcinoma, Non-Small-Cell Lung | Adenocarcinoma, Bronchiolo-AlveolarUnited States
-
Francisco Robert,MDSanofi; BayerTerminatedNon Small Cell Lung Cancer | Non Squamous Cell Lung CancerUnited States
-
Xspray Pharma ABCompletedPharmacokinetics | BioavailabilityUnited Kingdom
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)Completed
-
The University of Hong KongCompletedAML | FLT3-ITD MutationHong Kong
-
Amsterdam UMC, location VUmcCompleted
-
UNC Lineberger Comprehensive Cancer CenterBayer; Amgen; Doris Duke Charitable FoundationCompletedKidney CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedKidney Cancer | Metastatic CancerUnited States
-
Sichuan UniversityUnknownUnresectable Hepatocellular Cancer | Portal Vein Tumor Thrombus
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Tirgan, Michael H., M.D.Terminated
-
Suleiman MassarwehBayerTerminated
-
Mahidol UniversityBayerCompletedRenal Cell CarcinomaThailand